Clinical Trail

Showing 1 posts of 1 posts found.

biogen_austria_238

Biogen fails to meet primary endpoint in XLRP study

May 17, 2021
Sales and Marketing Biogen, Clinical Trail

Biogen have released topline results from its Phase2/3 Xirius study of cotoretigene toliparvovec (BIIB112) as a gene therapy for patients …

Latest content